Relapsed or Refractory B-cell Malignancies research hub

Dose Determining Study of EXS73565 in Participants With Relapsed or Refractory B-Cell Malignancies

This study is testing a new medicine called EXS73565 for people with certain types of B-cell cancers that have come back or not responded to usual treatments. We want to find a safe dose and see how it works.